Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 31,774 shares of the construction company’s stock, valued at approximately $203,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Exchange Traded Concepts LLC boosted its position in shares of Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company’s stock valued at $48,000 after acquiring an additional 6,109 shares during the period. CWM LLC raised its holdings in shares of Aspen Aerogels by 2,137.9% in the 1st quarter. CWM LLC now owns 8,325 shares of the construction company’s stock valued at $53,000 after acquiring an additional 7,953 shares in the last quarter. Teacher Retirement System of Texas bought a new stake in Aspen Aerogels during the first quarter valued at approximately $65,000. Sandia Investment Management LP purchased a new position in Aspen Aerogels in the fourth quarter worth $89,000. Finally, Concurrent Investment Advisors LLC purchased a new stake in Aspen Aerogels during the first quarter valued at about $109,000. 97.64% of the stock is currently owned by institutional investors.
Aspen Aerogels Price Performance
ASPN opened at $7.85 on Tuesday. The firm has a market cap of $644.56 million, a price-to-earnings ratio of -2.25 and a beta of 2.73. Aspen Aerogels, Inc. has a 1 year low of $4.16 and a 1 year high of $33.15. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.22 and a quick ratio of 3.53. The stock’s 50 day simple moving average is $6.59 and its 200 day simple moving average is $7.14.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Barclays reiterated an “equal weight” rating and set a $7.00 price objective (down from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th. Oppenheimer cut shares of Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels has an average rating of “Moderate Buy” and an average price target of $18.44.
Check Out Our Latest Report on Aspen Aerogels
Insider Buying and Selling
In related news, CEO Donald R. Young purchased 20,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The stock was bought at an average cost of $5.35 per share, with a total value of $107,000.00. Following the completion of the purchase, the chief executive officer directly owned 550,856 shares in the company, valued at approximately $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.40% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- What is a Dividend King?
- Analysts Make a Quantum Bet on D-Wave’s Cryogenic Packaging
- Trading Halts Explained
- Traders Turn Bullish on Housing Stocks Again—3 Leading the Way
- Insider Buying Explained: What Investors Need to Know
- Onsemi’s August Pullback Is a Signal to Buy for Tech Investors
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.